学科主题 | 药理学 |
新药Ⅳ期临床试验与药品上市后再评价的异同点以及存在的问题 | |
其他题名 | Similarities and differences of new drug phase Ⅳ clinical trials and post -marketing drug evaluation as well as existing problems |
单爱莲1; 蒋玉凤1 | |
关键词 | 药品上市后再评价 新药ⅳ期临床试验 具“药品促销倾向”的临床验证试验 新药审批办法 药品注册管理办法 Post-marketing Drug Evaluation New Drug Phase Ⅳclini-cal Trial Clinically Verified Trials Having Inclination To Pharmaceutical Promotion Regulations For New Drug Approval Regulations For Registration And Management Of New Drug |
刊名 | 中国临床药理学杂志
![]() |
2014 | |
DOI | 10.3969/j.issn.1001-6821.2014.05.001 |
期 | 5页:387-390,396 |
收录类别 | 中国科技核心期刊 ; 中文核心期刊 ; CSCD |
文章类型 | Journal Article |
摘要 | 本文将新药Ⅳ期临床试验与药品上市后再评价的相关政策背景进行了追溯,对两者的异同点进行了比较,并对存在的问题进行了探讨;同时,对具“药品促销倾向”的临床验证试验的特点进行了阐述,期望通过比较三者的区别,为临床医师与药师等明确临床试验的研究目的与范围、为临床合理用药提供研究数据。 With the retrospection of the background information of new drug phase Ⅳ clinical trials and post -marketing drug evaluation , this paper compared their similarities and differences and explored the exist-ing problems.Meanwhile , it illustrated the characteristics of clinically verified trials having inclination to pharmaceutical promotion , anticipating helping clinicians and clinical pharmacists clarify the purpose and range of clinical trials, and providing data for clinical rational drug use by dis-tinguishing among new drug phase IV clinical trial , post-marketing drug evaluation and clinical trials having inclination to pharmaceutical promotion. |
语种 | 中文 |
原文出处 | 查看原文 |
Citation statistics | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.bjmu.edu.cn/handle/400002259/44261 |
Collection | 北京大学第一临床医学院_临床药理研究所 |
作者单位 | 1.北京大学 第一医院 临床药理研究所,北京,100034 2.新疆自治区人民医院 临床药学研究所,乌鲁木齐,830001 |
Recommended Citation GB/T 7714 | 单爱莲,蒋玉凤. 新药Ⅳ期临床试验与药品上市后再评价的异同点以及存在的问题[J]. 中国临床药理学杂志,2014(5):387-390,396. |
APA | 单爱莲,&蒋玉凤.(2014).新药Ⅳ期临床试验与药品上市后再评价的异同点以及存在的问题.中国临床药理学杂志(5),387-390,396. |
MLA | 单爱莲,et al."新药Ⅳ期临床试验与药品上市后再评价的异同点以及存在的问题".中国临床药理学杂志 .5(2014):387-390,396. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment